Alivus Life Sciences Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
ALIVUS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Alivus Life Sciences has informed the exchanges that its Board of Directors will meet on Thursday, May 15, 2025. The board will consider and approve the audited financial results for the quarter and full year ended March 31, 2025. The board will also consider and recommend a dividend, if any, on equity shares for FY25. The trading window for designated persons has been closed from March 31, 2025 to May 17, 2025 (both days inclusive) in line with SEBI insider trading rules. This is a routine compliance filing ahead of the company's full-year results.
Investors should watch the May 15 board meeting for the FY25 results and any dividend announcement, which could influence the stock price. The closed trading window is a standard regulatory requirement and does not, by itself, signal any positive or negative news.